Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
A unique mutator phenotype reveals complementary oncogenic lesions leading to acute leukemia
Mianmian Yin, Timour Baslan, Robert L. Walker, Yuelin J. Zhu, Amy Freeland, Toshihiro Matsukawa, Sriram Sridharan, André Nussenzweig, Steven C. Pruitt, Scott W. Lowe, Paul S. Meltzer, Peter D. Aplan
Mianmian Yin, Timour Baslan, Robert L. Walker, Yuelin J. Zhu, Amy Freeland, Toshihiro Matsukawa, Sriram Sridharan, André Nussenzweig, Steven C. Pruitt, Scott W. Lowe, Paul S. Meltzer, Peter D. Aplan
View: Text | PDF
Research Article Genetics Hematology

A unique mutator phenotype reveals complementary oncogenic lesions leading to acute leukemia

  • Text
  • PDF
Abstract

Mice homozygous for a hypomorphic allele of DNA replication factor minichromosome maintenance protein 2 (designated Mcm2cre/cre) develop precursor T cell lymphoblastic leukemia/lymphoma (pre-T LBL) with 4–32 small interstitial deletions per tumor. Mice that express a NUP98-HOXD13 (NHD13) transgene develop multiple types of leukemia, including myeloid and T and B lymphocyte. All Mcm2cre/cre NHD13+ mice develop pre-T LBL, and 26% develop an unrelated, concurrent B cell precursor acute lymphoblastic leukemia (BCP-ALL). Copy number alteration (CNA) analysis demonstrated that pre-T LBLs were characterized by homozygous deletions of Pten and Tcf3 and partial deletions of Notch1 leading to Notch1 activation. In contrast, BCP-ALLs were characterized by recurrent deletions involving Pax5 and Ptpn1 and copy number gain of Abl1 and Nup214 resulting in a Nup214-Abl1 fusion. We present a model in which Mcm2 deficiency leads to replicative stress, DNA double strand breaks (DSBs), and resultant CNAs due to errors in DNA DSB repair. CNAs that involve critical oncogenic pathways are then selected in vivo as malignant lymphoblasts because of a fitness advantage. Some CNAs, such as those involving Abl1 and Notch1, represent attractive targets for therapy.

Authors

Mianmian Yin, Timour Baslan, Robert L. Walker, Yuelin J. Zhu, Amy Freeland, Toshihiro Matsukawa, Sriram Sridharan, André Nussenzweig, Steven C. Pruitt, Scott W. Lowe, Paul S. Meltzer, Peter D. Aplan

×

Figure 6

CNA analysis of BCP-ALL.

Options: View larger image (or click on image) Download as PowerPoint
CNA analysis of BCP-ALL.
(A) CNA analysis of germline and BCP-ALL (Mcm2c...
(A) CNA analysis of germline and BCP-ALL (Mcm2cre/cre NHD13+ [n = 7] and Mcm2cre/wt NHD13+ [n = 4] mice); samples were more than 60% tumor tissue (BM) based on flow cytometry. The IDs of Mcm2cre/cre NHD13+ mice are indicated on the right side. Color code as in Figure 2A. (B and C) CNAs for Pax5 region (B) and Cebpb/Ptpn1 region (C). Color code as in Figure 2A. (D) PCR amplification of Ptpn1-deleted region. Faint signals in 2703 and 2725 could be due to haploinsufficiency or contamination with nonmalignant cells. (E) Ptpn1 mRNA expression, samples, and copy number of Ptpn1 (CNAs) are indicated. Error bars represent standard deviation of 3 technical replicates (n = 3). mRNA expression is markedly decreased in samples with 2 copies lost.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts